Treatment of Infections Caused by Rhodococcus equi

• Autores: Steeve Giguère
• Localización: Veterinary Clinics of North America: Equine Practice: Equine Practice, ISSN-e 0749-0739, Vol. 33, Nº. 1, 2017, págs. 67-85
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Pneumonia caused by Rhodococcus equi remains an important cause of disease and death in foals. The combination of a macrolide (erythromycin, azithromycin, or clarithromycin) with rifampin remains the recommended therapy for foals with clinical signs of infection caused by R equi. Most foals with small, subclinical ultrasonographic pulmonary lesions associated with R equi recover without therapy, and administration of antimicrobial agents to these subclinically affected foals does not hasten lesion resolution relative to administration of a placebo. Resistance to macrolides and rifampin in isolates of R equi is increasing.